Pharmacovigilance today - how does patient adherence fit in?
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Presentation
- By: OLSSON, Sten (Uppsala Monitoring Centre, Uppsala, Sweden)
- Co-author(s): Sten Olssen:
The science and practice of pharmacovigilance (PV) has developed and expanded dramatically since the WHO Programme for International Drug Monitoring was initiated almost 50 years ago. The WHO definition of PV, published in 2002, includes not only adverse effects but also all other drug-related problems. PV has widened its scope to also become.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.